RE:RE:RE:RE:Just a thought...These same kind of people also think Beleave is already worth more than THC Biomed in market cap. It doesn't seem to even matter that they're another year away from sales license and haven't sold a single product.
maritimedreamer wrote: I agree with you QcTrader, but my thoughts go with the many that truly do not understand the market/players so they will in turn migrate to the CGC,ACB,APH, OGI,MJN etc... as those are the ones with a higher valuation. I see THC as very much the underdog and I like that. When financials become more important than hype we will be in a good position. We just have a long road ahead of us.... like others say which I agree with.... it will take a few quarterly's to entise people to look our direction. I think it was a smart move to be a leader in the clone shipping market as they know everyone else solely focused on Dried sales. Now that we are established in clone we can now pivot to the dried as we still have over a year before anything really picks up.